IpsenLTS:0MH6 -3.71%95 Days Inventory is 105.97 as of Dec. 2025, which is 30% below its 10-year median of 151.62. GuruFocus rates LTS:0MH6 with a GF Score™ of 95/100 and a GF Value™ of €134.05 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 919 Drug Manufacturers companies, Ipsen ranks better than 66.59% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Ipsen's Average Total Inventories for the
six
months ended in Dec. 2025 was €247 Mil. Ipsen's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €426 Mil.
Hence, Ipsen's Days Inventory for the
six
months ended in Dec. 2025 was 105.97.
The historical rank and industry rank for Ipsen's Days Inventory or its related term are showing as below:
LTS:0MH6'
s Days Inventory Range Over the Past 10 Years
Min: 114.72 Med: 151.62 Max: 183.27
Current: 126.38
During the past 13 years, Ipsen's highest Days Inventory was 183.27. The lowest was 114.72. And the median was 151.62.
LTS:0MH6's Days Inventory is ranked better than 66.59% of 919
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs LTS:0MH6: 126.38
Ipsen's Days Inventory
declined
from Dec. 2024 (131.38) to Dec. 2025 (105.97).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ipsen's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.72.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ipsen's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.12.
Ipsen (LTS:0MH6) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ipsen's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ipsen's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ipsen Days Inventory Related Terms
Ipsen Days Inventory Historical Data
* Premium members only.
The historical data trend for Ipsen's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0MH6 vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ipsen Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ipsen's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ipsen's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ipsen (LTS:0MH6) has a Days Inventory of 105.97 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ipsen and its competitors. This is 30% below median its historical median of 151.62. Over the past decade, Ipsen's Days Inventory has ranged from 114.72 to 183.27. According to the industry distribution chart, Ipsen ranks #307 out of 919 companies in the Drug Manufacturers industry, placing it in the top 33.4%.
Is Ipsen's Days Inventory too high?
Ipsen's current Days Inventory of 105.97 is 30% below median its 10-year median of 151.62. Over the past 10 years, this metric has ranged from a low of 114.72 to a high of 183.27. The Drug Manufacturers industry median Days Inventory is 164.38. Ipsen's value of 105.97 is 35.5% below this industry median. Based on the distribution chart, Ipsen ranks #307 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ipsen has a GF Score™ of 95/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ipsen's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ipsen ranks #307 out of 919 companies for Days Inventory. This puts Ipsen in the upper half of its industry. The industry median Days Inventory is 164.38. Ipsen's value of 105.97 is 35.5% below this benchmark. Historically, Ipsen's own Days Inventory has ranged from 114.72 to 183.27 over the past decade. While the company's 10-year median is 151.62 vs. the industry median of 164.38, Ipsen has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ipsen's current Days Inventory of 105.97 is 35.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ipsen and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ipsen's current Days Inventory is 105.97, which is 30% below median its own 10-year median of 151.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ipsen stock overvalued right now?
Based on GuruFocus' analysis, Ipsen (LTS:0MH6) is currently considered Modestly Overvalued. The stock's GF Value™ is €134.05, compared to a current price of €162.05 — trading 20.9% above its estimated fair value. The current Days Inventory is 105.97, which is 30% below median its 10-year median of 151.62 and 35.5% below the Drug Manufacturers industry median of 164.38. Ipsen's overall GF Score™ is 95/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ipsen (LTS:0MH6), the current Days Inventory is 105.97 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ipsen (LTS:0MH6) Overvalued in 2026?
Based on GuruFocus' analysis, Ipsen stock appears to be overvalued.
The current stock price of €162.05 is trading 20.9% above its estimated GF Value™ of €134.05.
GuruFocus considers Ipsen to be Modestly Overvalued.
Key valuation signals for LTS:0MH6:
Days Inventory: 105.97 (30% below median its 10-year median of 151.62)
GF Value™: €134.05 vs. price of €162.05 (20.9% above fair value)
Industry Position: 35.5% below the Drug Manufacturers median (#307 of 919)
No single metric tells the full story. See the LTS:0MH6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 20 drugs in 115 countries.
95GF Score
Get the complete analysis for LTS:0MH6
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0MH6 has been successfully added to your 
